<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01765010</url>
  </required_header>
  <id_info>
    <org_study_id>SNUH-ENDO-2013</org_study_id>
    <nct_id>NCT01765010</nct_id>
  </id_info>
  <brief_title>The Effect of Inactive and Active Vitamin D on Serum Sclerostin/dickkopf1 Levels</brief_title>
  <official_title>Comparisons of the Effect of Inactive and Active Vitamin D on Serum Sclerostin/dickkopf1 Levels</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effect of inactive and active vitamin D on serum
      sclerostin and dickkopf1 levels.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">March 2013</completion_date>
  <primary_completion_date type="Anticipated">March 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of serum sclerostin level</measure>
    <time_frame>8 weeks later</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of serum Dickkopf1 level</measure>
    <time_frame>8 weeks later</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of serum c-telopeptide level</measure>
    <time_frame>8 weeks later</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of serum bone-specific alkaline phosphatase level</measure>
    <time_frame>8 weeks later</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of serum calcium level</measure>
    <time_frame>8 weeks later</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of serum parathyroid hormone level</measure>
    <time_frame>8 weeks later</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">88</enrollment>
  <condition>Osteoporosis</condition>
  <arm_group>
    <arm_group_label>Placebo control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cholecalciferol 1000IU</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cholecalciferol 1000IU qd for 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>alfacalcidol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>alfacalcidol 0.5ug qd for 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Calcitriol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Calcitriol 0.25ug qd for 8 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Calcitriol</intervention_name>
    <arm_group_label>Calcitriol</arm_group_label>
    <other_name>Calcio</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Alfacalcidol</intervention_name>
    <arm_group_label>alfacalcidol</arm_group_label>
    <other_name>Onealfa</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cholecalciferol</intervention_name>
    <arm_group_label>Cholecalciferol 1000IU</arm_group_label>
    <other_name>DicamaxD</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy male volunteer older than 20 years

        Exclusion Criteria:

          -  Subjects with bone and mineral metabolism disorders

          -  Subjects with kidney or liver diseases

          -  Subjects with uncorrectable hypercalcemia or hypocalcemia

          -  Subjects with chronic gastrointestinal disorders or malabsorption

          -  Subjects taking medication related to bone loss
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chan Soo Shin, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chan Soo Shin, MD, PhD</last_name>
    <phone>+82-2-2072-3734</phone>
    <email>csshin@snu.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jung Hee Kim, MD</last_name>
    <phone>+82-2-2072-4839</phone>
    <email>jhkxingfu@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Medical School</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chan Soo Shin, MD, PhD</last_name>
      <phone>82220723734</phone>
      <email>csshin@snu.ac.kr</email>
    </contact>
    <contact_backup>
      <last_name>Jung Hee Kim, MD</last_name>
      <phone>8220724839</phone>
      <email>jhkxingfu@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Chan Soo Shin, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 8, 2013</study_first_submitted>
  <study_first_submitted_qc>January 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 10, 2013</study_first_posted>
  <last_update_submitted>January 8, 2013</last_update_submitted>
  <last_update_submitted_qc>January 8, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 10, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Vitamin D</keyword>
  <keyword>Serum sclerostin</keyword>
  <keyword>Serum dickkopf1</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Calcitriol</mesh_term>
    <mesh_term>Hydroxycholecalciferols</mesh_term>
    <mesh_term>Alfacalcidol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

